Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,809
-$3,057 QoQ
Shares Held
936
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 39 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vanguard Global Advisers, LLC holds $170,283,439 across 44 Drug Manufacturers - Specialty & Generic names. SCYX ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
954,734 | $68,607,185 | |
| 2 | VTRS |
Viatris Inc
|
2,699,149 | $42,862,486 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
17,345 | $9,398,041 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
38,679 | $6,518,958 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
200,037 | $4,922,910 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
855,700 | $4,218,601 | |
| 7 | ALKS |
Alkermes plc.
|
63,665 | $3,336,046 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
81,988 | $2,842,523 |
All Filings in SCYX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,809 | 936 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,866 | 7,488 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||